Tudor Investment Corp
DNTH icon

Tudor Investment Corp’s Dianthus Therapeutics DNTH Stock Holding History

Tudor Investment Corp’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,842
Closed -$200K – 1386
2020
Q3 		$200K Sell
1,842
-296
-14% -$35.1K 0.01% 1137
2020
Q2 		$257K Buy
+2,138
New +$301K 0.01% 929
2018
Q3 		– Sell
-625
Closed -$135K – 1115
2018
Q2 		$135K Buy
+625
New +$141K ﹤0.01% 966

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Tudor Investment Corp's DNTH Position: Q4 2020 in Review

Tudor Investment Corp sold out of Dianthus Therapeutics (DNTH) in Q4 2020, closing a stake of 1,842 shares — an estimated $200K sold.

Tudor Investment Corp first reported a position in DNTH in Q2 2018 and held it in 3 quarters. The position peaked at $257K in Q2 2020. 92 funds tracked by Wall St. Rank hold DNTH as of Q4 2020.

  • Tudor Investment Corp reported no remaining Dianthus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 1,842 Dianthus Therapeutics shares in Q4 2020, an estimated $200K.
  • Tudor Investment Corp first reported a position in Dianthus Therapeutics in Q2 2018 and held it in 3 quarters.
  • Tudor Investment Corp's Dianthus Therapeutics position peaked at $257K in Q2 2020.
  • 92 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q4 2020.

Based on Tudor Investment Corp's 13F filing for Q4 2020, filed 16 Feb 2021.